跳至主要内容
临床试验/IRCT20220502054721N1
IRCT20220502054721N1招募中3 期

The effect of davayebalgham capsule (a Persian medicine product) and acupuncture on blood sugar and lipid profile of type 2 diabetic patients (a randomized clinical study)

Tehran University of Medical Sciences0 个研究点目标入组 105 人开始时间: 待定最近更新:
适应症

试验速览

阶段
3 期
状态
招募中
入组人数
105

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20 years 至 65 years(—)
性别
All

入选标准

  • Type 2 Diabetes patients
  • Taking oral hypoglycemic drugs
  • Age 20-65 years
  • Satisfaction to enter the plan
  • HbA?C < %?

排除标准

  • Having serious gastrointestinal diseases including active stomach ulcers and gastrointestinal bleeding
  • History of diabetic ketoacidosis, non-ketone hyperosmolar diabetic coma, severe infection or surgery in the previous month
  • Kidney failure, liver dysfunction, cancers, cysts or breast mass, metabolic diseases
  • Having a psychological illness
  • Consumption of alcohol, drugs or psychotropic substances
  • Uncontrolled hypertension (blood pressure greater than or equal to 100/160 mm Hg)
  • History of myocardial infarction
  • Taking anticoagulants (warfarin and Plavix ...)
  • Insulin therapy over the past three months
  • Continued use of herbs or other herbal medicines
  • Fasting blood sugar above 180
  • Pregnancy, breastfeeding
  • Having allergies to any of the plants

研究者

相似试验